BEX5 (brain expressed X-linked 5) is an X-linked gene encoding a cytoplasmic protein involved in signal transduction and protein binding 1. Originally identified through screens for ventral mesencephalic dopamine neuron development genes, BEX5 is present in humans and primates but absent from rodents 1. The protein localizes to the cytoplasm and undergoes proteasomal degradation, distinguishing it from some BEX family members 1. In cancer biology, BEX5 exhibits context-dependent roles. It is ectopically expressed in T-cell acute lymphoblastic leukemia (T-ALL), particularly in samples overexpressing the TAL1 oncogene, where BEX1/2/5 may function as TAL1 cofactors to dysregulate histone marks and gene expression 2. Conversely, BEX5 demonstrates favorable prognostic significance in lung adenocarcinoma and uveal melanoma, serving as a component of multi-gene risk stratification models where high expression correlates with better patient outcomes 34. In thyroid cancer, BEX5 contributes to a 7-gene prognostic signature associated with cell cycle regulation and treatment response 5. Recent evidence suggests BEX5 participates in shared immune-inflammatory pathways between psoriasis and type 2 diabetes mellitus 6. BEX5's tissue-wide expression and roles in both normal development and malignant pathways indicate pleiotropic functions requiring further mechanistic clarification.